Chemically related 4,5-linked aminoglycoside antibiotics drive subunit rotation in opposite directions

Michael Wasserman, Arto Pulk, Zhou Zhou, Russ B. Altman, John C. Zinder, Keith Green, Sylvie Garneau‐Tsodikova, J.h.d. Cate, Scott C. BlanchardNature Communications 2015 · DOI

TL;DR

This study reveals that chemically similar aminoglycoside antibiotics, neomycin and paromomycin, which differ only by a single functional group, can drive bacterial ribosome subunit rotation in opposite directions. This finding, supported by single-molecule FRET and crystal structures, suggests that the precise chemical structure of these antibiotics dictates their distinct impacts on translation, with implications for antibiotic resistance and toxicity.

What Problem Does This Paper Address?

Aminoglycoside antibiotics are potent antibacterial agents that target the bacterial ribosome, but their clinical use is often limited due to toxic side effects. While it's known that these drugs can interfere with translation by binding to specific regions of the ribosome, the precise molecular mechanisms behind their varying efficacy, toxicity, and resistance profiles remain unclear. Specifically, how subtle chemical differences between related aminoglycosides lead to distinct functional outcomes on the ribosome's dynamic movements, particularly subunit rotation, has been a significant question. This paper aims to bridge this gap by investigating the structure-function relationships of 4,5-linked aminoglycosides and their impact on ribosome subunit rotation.

Methods

The researchers employed a multi-pronged approach:

  • Single-molecule Förster Resonance Energy Transfer (smFRET): This is the core technique used to observe ribosome subunit rotation in real-time. Ribosomal proteins S13 (small subunit) and L1 (large subunit) were site-specifically labeled with donor and acceptor fluorophores. By measuring the distance between these fluorophores, the researchers could track the dynamic intersubunit rotation of the ribosome. They utilized intra-molecularly stabilized fluorophores for improved brightness and photostability, allowing for higher time resolution and signal-to-noise ratios.
  • X-ray Crystallography: The crystal structure of the paromomycin-70S ribosome complex was solved at 3.1 Å resolution. This provided high-resolution snapshots of the drug's interaction with the ribosome, complementing the dynamic smFRET data.
  • In vitro Transcription-Translation Assays: These assays were used to measure the inhibitory concentration (IC50) of various aminoglycosides on protein synthesis, providing a functional readout of their impact on translation.
  • Mutagenesis Studies: The researchers used ribosomes with a specific point mutation (A1408G) in the h44 region, known to confer aminoglycoside resistance, to investigate the role of this binding site.
  • Dynamic Modeling: Hidden Markov modeling was used to analyze the smFRET data and identify distinct FRET states corresponding to different ribosome configurations.

Datasets

Not explicitly discussed in the paper as distinct datasets for training or evaluation. The primary "datasets" are the smFRET trajectories collected from single ribosome complexes and the structural data obtained from X-ray crystallography.

Key Insights and Ideas

  • Opposing Rotation Directions: The most striking finding is that neomycin and paromomycin, differing only by a 6'-polar group (amine vs. hydroxyl), drive subunit rotation in opposite directions. This highlights the exquisite sensitivity of ribosome dynamics to subtle chemical modifications.
  • Functional Linkage of Binding Sites: The study reinforces the idea that the h44 (small subunit) and H69 (large subunit) binding sites for aminoglycosides are functionally linked. Binding at one site influences the dynamics and potentially the binding at the other.
  • Role of the 6'-Substituent: The 6'-hydroxyl group of paromomycin appears crucial for its interaction with residue A1913 at the tip of H69, leading to stabilization of the unrotated state. This suggests a specific molecular interaction driving the opposite rotational effect compared to neomycin.
  • Dynamic vs. Static Structures: The crystal structure revealed a key difference in the dynamics of residue A1913 between neomycin- and paromomycin-bound ribosomes, with A1913 being more dynamic in the presence of neomycin and more static with paromomycin. This dynamic difference is linked to the observed opposite rotational effects.
  • Implications for Resistance and Toxicity: The distinct impacts on subunit rotation suggest that aminoglycoside resistance and toxicity mechanisms might be more complex than previously thought, involving not just binding affinity but also the modulation of ribosome dynamics.

Key Results

  • Neomycin and paromomycin exhibited similar IC50 values (14–20 nM) for inhibiting in vitro translation in wild-type ribosomes, suggesting comparable overall inhibitory potency.
  • Neomycin, at low concentrations, stabilized the unrotated ribosome configuration and the intermediate-FRET state, while at higher concentrations, it preferentially stabilized the intermediate-FRET state, leading to a significant decrease in intersubunit dynamics.
  • Paromomycin, in contrast, preferentially stabilized the low-FRET, unrotated ribosome configuration across all tested concentrations, and at lower concentrations, it markedly increased subunit rotation dynamics.
  • Ribosomes with the A1408G mutation (resistant to aminoglycosides at h44) showed altered responses to both neomycin and paromomycin, with neomycin's effect on stabilizing intermediate states being reduced, and paromomycin's effect on stabilizing the unrotated state being largely absent at lower concentrations.
  • The crystal structure of the paromomycin-ribosome complex revealed specific contacts between paromomycin's 6'-hydroxyl group and the conserved residue A1913 in H69, which was not observed with neomycin.

Limitations and Future Work

  • Context Dependency: The authors acknowledge that the impact of aminoglycosides can be context-dependent, and further investigations into distinct ribosome complexes during processive translation are needed.
  • H69 Resistance Mutations: While h44 mutations are common for aminoglycoside resistance, mutations in H69 are rare, suggesting a potential difference in evolutionary pressure or functional constraints. The paper notes that attempts to create H69 resistance mutations only led to modest effects.
  • Kinetic Parameters: While the study provides insights into steady-state effects, a more quantitative understanding of aminoglycoside association and dissociation rates (on- and off-rates) for both h44 and H69 binding sites is suggested as crucial for a complete picture.
  • Eukaryotic Ribosomes: The paper briefly touches upon potential implications for eukaryotic ribosomes, noting that they preferentially adopt rotated states, which might contribute to aminoglycoside resistance in eukaryotes. This could be an avenue for future research.
  • Drug Concentration and pH: The study highlights the importance of considering drug concentration and pH, as these factors can influence drug binding avidity and thus impact ribosome dynamics.

Summary updated

Abstract

Dynamic remodelling of intersubunit bridge B2, a conserved RNA domain of the bacterial ribosome connecting helices 44 (h44) and 69 (H69) of the small and large subunit, respectively, impacts translation by controlling intersubunit rotation. Here we show that aminoglycosides chemically related to neomycin-paromomycin, ribostamycin and neamine-each bind to sites within h44 and H69 to perturb bridge B2 and affect subunit rotation. Neomycin and paromomycin, which only differ by their ring-I 6'-polar group, drive subunit rotation in opposite directions. This suggests that their distinct actions hinge on the 6'-substituent and the drug's net positive charge. By solving the crystal structure of the paromomycin-ribosome complex, we observe specific contacts between the apical tip of H69 and the 6'-hydroxyl on paromomycin from within the drug's canonical h44-binding site. These results indicate that aminoglycoside actions must be framed in the context of bridge B2 and their regulation of subunit rotation.
BibTeX
@inproceedings{wasserman2015chemically,
  author = {Michael Wasserman and Arto Pulk and Zhou Zhou and Russ B. Altman and John C. Zinder and Keith Green and Sylvie Garneau‐Tsodikova and J.H.D. Cate and Scott C. Blanchard},
  title = {{Chemically related 4,5-linked aminoglycoside antibiotics drive subunit rotation in opposite directions}},
  booktitle = {Nature Communications},
  year = {2015},
  doi = {10.1038/ncomms8896},
}

Loading related content...

Figure